Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
6 holders
Ownership
Activity
Fundamentals
2015 Q2
43 of 52 quarters
Total Value
$561.03M
Total Shares
4.79M
Net Share Change
+3.25M
Activity
2 buying
3 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$468.26M
4.00M
5.9%
ADD
+3.21M
(+406.0%)
Egerton Capital
$468.26M
4.00M shares
ADD
+3.21M
(+406.0%)
Miller Value Partners
$63.12M
539.1K
2.2%
Unchanged
Miller Value Partners
$63.12M
539.1K shares
Unchanged
Matrix Asset Advisors
$19.27M
164.6K
2.4%
TRIM
-11.5K
(-6.5%)
Matrix Asset Advisors
$19.27M
164.6K shares
TRIM
-11.5K
(-6.5%)
Bridgewater Associates LP
$9.57M
81.7K
0.1%
ADD
+56.5K
(+224.0%)
Bridgewater Associates LP
$9.57M
81.7K shares
ADD
+56.5K
(+224.0%)
Jensen Investment Management
$543.0K
4.6K
0.0%
TRIM
-650
(-12.3%)
Jensen Investment Management
$543.0K
4.6K shares
TRIM
-650
(-12.3%)
Maverick Capital
$274.0K
2.3K
0.0%
TRIM
-310
(-11.7%)
Maverick Capital
$274.0K
2.3K shares
TRIM
-310
(-11.7%)
GILD — Gilead Sciences, Inc. - FilingSpy